The Independent Oncological Role for Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Cytoreductive Nephrectomy and the Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Metastatic RCC
- No Benefit With Lymph Node Dissection in Cytoreductive Nephrectomy for mRCC
- Metastatic Renal Cell Carcinoma Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy
- Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Treated With Targeted Therapies
- Even in the Targeted Therapy Era, Adding Cytoreductive Nephrectomy Improves Survival in Advanced RCC
- A Place for Cytoreductive Nephrectomy in mRCC
- MY APPROACH to the Use of Cytoreductive Nephrectomy for Metastatic RCC in the TKI Era
Urologic Oncology: Seminars and Original Investigations
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Independent Oncological Role for Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Prognostic Features in the Era of Targeted Therapies
Urol. Oncol 2017 Jan 30;[EPub Ahead of Print], T Claeys, N Lumen, C Kumps, M Praet, G De Meerleer, S Rottey, P Ost, P Devisschere, G Villeirs, V Fonteyne, K DecaesteckerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.